# Regulatory Overview

## Regulatory Framework Fundamentals

Medical device regulation is a complex multi-jurisdictional landscape designed to ensure patient safety and product efficacy.

## Global Regulatory Classification

### Risk-Based Classification Systems

| Region | Classification System | Classes |
|--------|---------------------|---------|
| United States (FDA) | Risk-based | Class I, II, III |
| European Union (MDR) | Rule-based | Class I, IIa, IIb, III |
| Korea (MFDS) | Risk-based | Class I, II, III, IV |

### Key Regulatory Authorities

- **FDA**: United States medical device regulator
- **European Commission**: Implements MDR 2017/745
- **MFDS**: Korean medical device regulator

## FDA Regulatory Pathways

### 510(k) - Premarket Notification

**Applicability:** Class II devices and some Class I/III devices

**Timeline:** Typically 3-6 months

**Key Sections:**
- 21 CFR 807.81: Contents of a 510(k) submission
- 21 CFR 807.87: Refuse to Accept (RTA) criteria

### PMA - Premarket Approval

**Applicability:** Class III devices (high-risk)

**Timeline:** Typically 6-12 months

**Key Sections:**
- 21 CFR 814: Premarket Approval of Medical Devices

## EU MDR Framework

### MDR 2017/745 Structure

**Key Annexes:**
- **Annex I**: Essential Requirements
- **Annex IX**: Clinical Evaluation
- **Annex XIV**: Clinical Evaluation Report (CER)

### CE Marking Process

1. Classification (Annex VIII rules)
2. Conformity Assessment
3. Technical Documentation (Annex II)
4. Clinical Evaluation (Annex IX/XIV)
5. Declaration of Conformity
6. CE Marking

---

**Version:** 1.0.0
**Last Updated:** 2026-02-09
